A total of 111 companies are scheduled to announce their third-quarter results on Feb. 3. Investors will be closely watching performance across key sectors such as mining, energy, infrastructure, finance, and healthcare, among others. Some of the major companies expected to announce earnings include Adani Enterprises Ltd., Adani Ports and Special Economic Zone Ltd., Bajaj Finance Ltd., Bharat Coking Coal Ltd., Varun Beverages Ltd. and NMDC Ltd.
Analysts and investors will be expecting updates on revenue, profits and key operational metrics. The results will provide insights into sectoral trends and the overall market outlook. After the results, many companies will also hold an earnings conference call to discuss the performance. Some may declare dividends to reward shareholders.
Major Companies Announcing Q3 Results On Feb. 3
Adani Enterprises Ltd., Adani Ports and Special Economic Zone Ltd., AWL Agri Business Ltd., Bajaj Finance Ltd., Bharat Coking Coal Ltd., Godrej Agrovet Ltd., JK Lakshmi Cement Ltd., DAM Capital Advisors Ltd., Expleo Solutions Ltd., Lloyds Metals and Energy Ltd., Mankind Pharma Ltd., One Mobikwik Systems Ltd., NMDC Ltd., PCBL Chemical Ltd., Pidilite Industries Ltd., Rubicon Research Ltd., Saregama India Ltd., Timex Group India Ltd., V2 Retail Ltd., Zydus Wellness Ltd., Varun Beverages Ltd..
Adani Ports and Special Economic Zone Q2FY26 Results
Adani Ports and Special Economic Zone Ltd. reported consolidated revenue up 30% YoY at Rs 9,167 crore from Rs 7,067 crore in Q2 FY25. Ebitda increased 27% YoY to Rs 5,550 crore v Rs 4,369 crore. Profit after tax (PAT) grew 29% YoY to Rs 3,120 crore, compared to Rs 2,413 crore a year earlier. Cargo handled also rose, reaching 124 million metric tonnes (MMT), up 12% from 111 MMT in the same quarter last year.
Pidilite Industries Q2FY26 Results
Pidilite Industries Ltd. reported consolidated revenue of Rs 3,540 crore in Q2 FY26, up 9.8% from the same quarter last year. Ebitda rose 10.7% YoY to Rs 851 crore. Ebitda margin was at 24%, consistent with Q2 FY25. Profit after tax (PAT) grew 8.3% to Rs 585 crore. Domestic subsidiaries posted strong growth of 10.7%.
Mankind Pharma Q2FY26 Results
Mankind Pharma Ltd. reported consolidated revenue of Rs 3,697 crore for Q2 FY26, up 20.8% from Rs 3,061 crore in the same quarter last year. Ebitda increased 8.7% YoY to Rs 924 crore versus Rs 850 crore in Q2FY25. Margins narrowed to 25.0% from 27.8% in Q2FY25. Profit after tax (PAT) fell 21.3% to Rs 520 crore, compared to Rs 661 crore a year ago.
Comprehensive Budget 2026 coverage, LIVE TV analysis, Stock Market and Industry reactions, Income Tax changes and Latest News on NDTV Profit.
